


Privacy policy & notice of privacy practices
Effective Date: October 18, 2026
This Privacy Policy and Notice of Privacy Practices describes how Oxytocin protects, uses, and discloses your personal and protected health information (PHI) in accordance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA), 42 CFR Part 2 (Confidentiality of Substance Use Disorder Patient Records), applicable Montana law, and other applicable federal regulations.
Please review this Notice carefully. It explains how we may use and disclose your information, your privacy rights, and our legal responsibilities regarding your information.
Table of Contents
-
Our Legal Responsibilities
-
How We Use and Disclose Your Health Information
-
Substance Use Disorder Records (42 CFR Part 2)
-
Mental Health Records
-
Telehealth & Electronic Services
-
Phone, Text, Email & Electronic Communications
-
Oxytocin Privacy Policy for SMS Messaging
-
Requests, Website & Electronic Forms
-
Third-Party Service Providers
-
Minors & Parent/Guardian Rights
-
Your Privacy Rights
-
Data Security & Retention
-
Changes to This Notice
-
Questions or Complaints
1. Our Legal Responsibilities
Oxytocin is required by law to:
-
Maintain the privacy and security of your protected health information (PHI).
-
Provide you with this Notice of Privacy Practices.
-
Notify you following a breach of unsecured protected health information when required by law.
-
Comply with HIPAA, 42 CFR Part 2, applicable Montana statutes, and other federal privacy laws.
We must follow the privacy practices described in this Notice.
2. How We Use and Disclose Your Health Information
Treatment
We may use and disclose your health information to provide, coordinate, or manage your care. This may include communication among clinicians, medical providers, peer support specialists, care managers, laboratories, pharmacies, hospitals, and other healthcare professionals involved in your treatment.
Payment
We may use and disclose your health information for payment purposes, including:
-
Insurance billing
-
Prior authorizations
-
Claims submission
-
Coordination of benefits
-
Payment collection
Please note that some services, including certain court-ordered evaluations and educational programs, are not billable to insurance.
Health Care Operations
We may use your information to:
-
Improve the quality of care
-
Conduct quality assurance activities
-
Maintain accreditation
-
Train staff
-
Perform audits
-
Meet licensing and regulatory requirements
-
Operate our organization
Individuals Involved in Your Care
With your written authorization or as otherwise permitted by law, we may share relevant information with family members, legal guardians, or other individuals involved in your care or payment.
Required by Law
We may disclose information when required by federal or Montana law, including reporting requirements related to abuse, neglect, court orders, public health reporting, or threats to health or safety.
3. Substance Use Disorder Records (42 CFR Part 2)
Because Oxytocin provides Substance Use Disorder treatment services, many client records are protected under 42 CFR Part 2, a federal law that provides additional confidentiality protections beyond HIPAA.
Except as specifically permitted by law, your written consent is required before we disclose information identifying you as having received substance use disorder services.
Disclosures without your written consent are limited to situations specifically authorized by federal law, including certain medical emergencies, research, audits, evaluations, and court orders that meet the requirements of 42 CFR Part 2.
4. Mental Health Records
Mental health records are protected under HIPAA and applicable Montana law.
Certain psychotherapy notes receive additional legal protections and generally cannot be disclosed without your separate written authorization, except in limited circumstances permitted by law.
5. Telehealth & Electronic Services
Oxytocin provides telehealth services through secure, HIPAA-compliant technology.
Although we use reasonable safeguards, electronic communications involve inherent privacy risks, including technical failures or unauthorized access beyond our control.
By participating in telehealth or submitting information electronically, you acknowledge these risks and consent to electronic communication when appropriate.
6. Phone, Text, Email & Electronic Communications
Oxytocin Clinic limits the information contained in electronic communications through Elevate, the Electronic Health Record (EHR), and Twilio to what is reasonably necessary for the intended communication. The clinic takes appropriate precautions to minimize unnecessary disclosure of confidential client information, including protected health information and substance use disorder treatment records, in accordance with applicable HIPAA and 42 CFR Part 2 requirements.
Automated appointment reminders and random drug and alcohol testing notifications are limited to necessary scheduling and testing information. Direct communications through Elevate may include additional treatment-related information when appropriate and authorized, subject to applicable privacy and confidentiality safeguards.
Direct Client Communication through Elevate
Oxytocin Clinic utilizes Elevate as its business telephone and messaging system to facilitate direct, two-way communication between clients and their assigned clinicians.
Through Elevate, clients may call or text their clinician with treatment-related questions, appointment scheduling, care coordination, and other service-related matters.
Unlike automated appointment reminders and random drug and alcohol testing notifications, Elevate allows clients and clinicians to communicate directly and respond to one another.
Message frequency varies based on client-initiated communication, clinical needs, and ongoing treatment coordination. Message and data rates may apply depending on the client's mobile carrier and service plan.
Elevate communications are separate from automated random testing notifications sent through Twilio. Clients should contact their assigned clinician directly through Elevate to request alternative testing arrangements or discuss individual treatment concerns.
Electronic communications may not be completely secure or confidential. Clients should be aware that messages may be visible to others with access to their devices. Elevate is not intended for emergency communication.
For emergencies, call 911.
Appointment Reminder Authorization through EHR
Automated appointment reminders through Oxytocin Clinic's Electronic Health Record (EHR) require separate, voluntary written authorization.
Clients must affirmatively select their preferred communication method, including SMS or email, and sign Oxytocin Clinic's Authorization for Appointment Reminders form before receiving automated appointment notifications.
No client is enrolled in the automated appointment reminder program, and no automated reminders are sent, until the clinic obtains written authorization.
The authorization form identifies the available communication methods and explains the purpose of appointment reminders and applicable communication preferences.
Clients who decline or do not provide authorization are not enrolled in the automated appointment reminder program and therefore do not need to opt out.
Clients who previously authorized appointment reminders may withdraw or modify their authorization at any time by contacting Oxytocin Clinic directly. The clinic will update their communication preferences and discontinue the affected notifications.
Consent to receive automated appointment reminders is voluntary and is not a condition of receiving treatment. Declining or revoking authorization does not excuse clients from attending scheduled appointments or fulfilling other treatment and monitoring requirements.
Authorization for EHR appointment reminders does not automatically authorize Twilio random drug and alcohol testing notifications. Each program requires its own written authorization.
Random Testing SMS Authorization through Twilio
Random drug and alcohol testing SMS notifications require separate, voluntary written authorization.
Clients must affirmatively select an initially unchecked YES option and sign Oxytocin Clinic's Authorization for Random Drug and Alcohol Testing Text Notifications form before we enroll them in the automated SMS notification program.
We do not enroll a client in the automated SMS notification program, and we do not send automated testing notifications, until we obtain written authorization.
The authorization form explains the purpose and type of messages, variable message frequency, potential message and data charges, and STOP/HELP instructions.
Clients who select NO or do not provide written authorization are not enrolled in the SMS notification program and therefore do not need to opt out. These clients must follow Oxytocin Clinic's established daily call-in procedures, Monday through Friday between 8:30 AM and 9:00 AM Mountain Time, to determine whether they have been selected for required testing.
Clients who previously authorized automated SMS notifications may revoke their consent at any time by replying STOP or contacting Oxytocin Clinic directly.
Consent to receive automated random testing notifications is voluntary and is not a condition of receiving treatment. Declining or revoking SMS authorization does not excuse clients from required drug and alcohol testing or other treatment and monitoring obligations.
Authorization for EHR appointment reminders does not automatically authorize Twilio random testing notifications, and authorization for Twilio random testing notifications does not automatically authorize EHR appointment reminders.
Message Frequency & Data Rates
Elevate Direct Client Communication
Elevate provides direct, two-way telephone and text messaging communication between clients and their assigned clinicians for treatment-related questions, appointment scheduling, care coordination, and other clinical needs.
Message frequency varies based on client-initiated communications, clinical needs, and ongoing treatment coordination. Unlike automated appointment reminders and random drug and alcohol testing notifications, Elevate communications do not follow a predetermined messaging schedule.
EHR Appointment Reminders
Appointment reminders are generally sent approximately 48 hours, 24 hours, and 1 hour before scheduled appointments.
Actual reminder frequency depends on the number of scheduled appointments and the client's authorized communication methods.
Twilio Random Testing Notifications
Random testing notifications are generally sent at approximately 7:00 AM Mountain Time on days when a client is selected for testing.
Message frequency varies depending on the client's treatment program and monitoring requirements, with a maximum of one testing notification per day and three testing notifications per week.
Message and Data Rates
Message and data rates may apply to SMS communications through Elevate, the Electronic Health Record (EHR), and Twilio, depending on the client's mobile carrier and service plan.
Consent and Communication Preferences
Appointment reminders and random testing notifications are separate communication programs operated through different systems and subject to separate authorization requirements.
Providing a telephone number or email address does not, by itself, constitute consent to receive automated text messages.
Clients may authorize appointment reminders without authorizing random testing SMS notifications, or authorize random testing SMS notifications without selecting SMS as an appointment-reminder method.
Participation in optional automated SMS notifications is voluntary and is not a condition of receiving treatment. Declining automated messaging does not eliminate the client's responsibility to attend scheduled appointments or complete required testing.
Clients may modify or revoke communication authorizations by contacting Oxytocin Clinic or using applicable messaging opt-out procedures.
Automated SMS Responses and Assistance
Random testing SMS notifications sent through Twilio are automated and are not monitored for individual conversations.
Clients may reply STOP to opt out of automated Twilio notifications or HELP to receive automated contact information.
Clients requiring nonemergency assistance or alternative testing arrangements must contact Oxytocin Clinic directly at (406) 314-6565.
Confidentiality and Communication Risks
Electronic communications, including SMS and email, may not be completely secure. Messages may be viewed by individuals who have access to the recipient's phone, voicemail, email account, or electronic devices.
Communications and related disclosures are managed in accordance with applicable HIPAA and 42 CFR Part 2 requirements.
Additional information about SMS consent, message frequency, opt-out procedures, information collection, and sharing practices is provided in Section 7 of this Privacy Policy.
We do not use these communications for marketing purposes.
Oxytocin does not accept requests via its website. To request services, appointments, documentation, records, billing, privacy rights, complaints, consent changes, or communication preferences, contact the office directly or use the client portal in the EHR.
Oxytocin Clinic does not sell or share mobile telephone numbers, SMS opt-in information, or messaging consent records with third parties or affiliates for marketing or promotional purposes. Information necessary to deliver authorized communications may be processed by approved service providers, including Elevate, the EHR provider, Twilio, and telecommunications carriers, subject to applicable privacy, confidentiality, and legal requirements.
Text Message Opt-Out
Clients may discontinue authorized SMS communications at any time.
For automated random drug and alcohol testing notifications sent through Twilio, reply STOP to opt out or HELP for assistance.
Clients may modify or revoke EHR appointment reminder authorization or request that Elevate communications cease by contacting Oxytocin Clinic directly.
Clients who request that all clinic telephone and text communications stop will have their communication preferences updated across Elevate, the EHR, and Twilio, as applicable.
Declining or revoking electronic communications does not eliminate treatment, appointment, testing, court, probation, or other monitoring responsibilities.
7. Oxytocin Privacy Policy for SMS Messaging
Links:
-
Terms and Conditions: https://www.oxytocinclinic.com/terms-and-conditions
-
Privacy Policy: https://www.oxytocinclinic.com/notice-of-privacy-practices
-
National Do Not Call Registry: https://www.donotcall.gov/
Introduction
Oxytocin maintains three separate electronic communication systems, each serving a distinct purpose:
-
Elevate: Provides direct, two-way telephone and text messaging communication between clients and their assigned clinicians under the clinic's general communication authorization.
-
Electronic Health Record (EHR): Sends automated appointment reminders and related scheduling notifications to clients who have provided separate written authorization.
-
Twilio: Provides automated random drug and alcohol testing notifications to clients who have affirmatively opted in through Oxytocin's separate written authorization process.
All three systems provide nonmarketing communications and operate according to the client's applicable authorization and communication preferences.
A. Information We Collect
Oxytocin collects and maintains information necessary to provide authorized communications, including:
-
Contact Information: Mobile telephone numbers and other authorized contact information.
-
Message Interaction Data: Message dates, transmission and delivery status when available, and supported response keywords.
-
Consent Records: Signed appointment reminder authorizations, signed random testing SMS authorizations, consent dates, selected communication preferences, and documented changes or revocations.
-
Messaging Records: Information necessary to administer notifications, document communication activities, and prevent messages following an opt-out.
Providing a mobile telephone number alone does not constitute authorization to receive automated SMS notifications.
B. How We Use Your Information
Oxytocin uses authorized contact and messaging information to:
-
Provide Direct Communication Through Elevate: Facilitate direct, two-way telephone calls and text messaging between clients and their assigned clinicians for treatment-related questions, appointment scheduling, care coordination, and other authorized clinical communications.
-
Provide EHR Appointment Reminders: Send appointment reminders and related scheduling notifications through Oxytocin's Electronic Health Record, based on the communication methods the client selects.
-
Provide Twilio Random Testing Notifications: Send same-day SMS notifications when an authorized client is selected for required random drug or alcohol testing.
-
Maintain and update client communication preferences.
-
Document consent, opt-out requests, and applicable messaging activity.
-
Monitor message transmission and delivery when available.
-
Support the administration, security, and reliability of authorized communication systems.
SMS information is used for authorized treatment-related and administrative communications, not promotional or marketing purposes.
C. One-to-One Consent Requirement
Oxytocin obtains and documents client consent for its messaging programs according to the applicable authorization process.
Direct Client Communication through Elevate
Oxytocin Clinic utilizes Elevate as its business telephone and messaging system to facilitate direct, two-way communication between clients and their assigned clinicians.
Through Elevate, clients may call or text their clinician with treatment-related questions, appointment scheduling, care coordination, and other service-related matters.
Unlike automated appointment reminders and random drug and alcohol testing notifications, Elevate allows clients and clinicians to communicate directly and respond to one another.
Message frequency varies based on client-initiated communication, clinical needs, and ongoing treatment coordination. Message and data rates may apply depending on the client's mobile carrier and service plan.
Elevate communications are separate from automated random testing notifications sent through Twilio. Clients should contact their assigned clinician directly through Elevate to request alternative testing arrangements or discuss individual treatment concerns.
Electronic communications may not be completely secure or confidential. Clients should be aware that messages may be visible to others with access to their devices. Elevate is not intended for emergency communication.
For emergencies, call 911.
Appointment Reminder Authorization through EHR
Automated appointment reminders through Oxytocin Clinic's Electronic Health Record (EHR) require separate, voluntary written authorization.
Clients must affirmatively select their preferred communication method, including SMS or email, and sign Oxytocin Clinic's Authorization for Appointment Reminders form before receiving automated appointment notifications.
No client is enrolled in the automated appointment reminder program, and no automated reminders are sent, until the clinic obtains written authorization.
The authorization form identifies the available communication methods and explains the purpose of appointment reminders and applicable communication preferences.
Clients who decline or do not provide authorization are not enrolled in the automated appointment reminder program and therefore do not need to opt out.
Clients who previously authorized appointment reminders may withdraw or modify their authorization at any time by contacting Oxytocin Clinic directly. The clinic will update their communication preferences and discontinue the affected notifications.
Consent to receive automated appointment reminders is voluntary and is not a condition of receiving treatment. Declining or revoking authorization does not excuse clients from attending scheduled appointments or fulfilling other treatment and monitoring requirements.
Authorization for EHR appointment reminders does not automatically authorize Twilio random drug and alcohol testing notifications. Each program requires its own written authorization.
Random Testing SMS Authorization through Twilio
Random drug and alcohol testing SMS notifications require separate, voluntary written authorization.
Clients must affirmatively select an initially unchecked YES option and sign Oxytocin Clinic's Authorization for Random Drug and Alcohol Testing Text Notifications form before we enroll them in the automated SMS notification program.
We do not enroll a client in the automated SMS notification program, and we do not send automated testing notifications, until we obtain written authorization.
The authorization form explains the purpose and type of messages, variable message frequency, potential message and data charges, and STOP/HELP instructions.
Clients who select NO or do not provide written authorization are not enrolled in the SMS notification program and therefore do not need to opt out. These clients must follow Oxytocin Clinic's established daily call-in procedures, Monday through Friday between 8:30 AM and 9:00 AM Mountain Time, to determine whether they have been selected for required testing.
Clients who previously authorized automated SMS notifications may revoke their consent at any time by replying STOP or contacting Oxytocin Clinic directly.
Consent to receive automated random testing notifications is voluntary and is not a condition of receiving treatment. Declining or revoking SMS authorization does not excuse clients from required drug and alcohol testing or other treatment and monitoring obligations.
Authorization for EHR appointment reminders does not automatically authorize Twilio random testing notifications, and authorization for Twilio random testing notifications does not automatically authorize EHR appointment reminders.
D. Message Frequency & Data Rates
Elevate Direct Client Communication
Elevate provides direct, two-way telephone and text messaging communication between clients and their assigned clinicians for treatment-related questions, appointment scheduling, care coordination, and other clinical needs.
Message frequency varies based on client-initiated communications, clinical needs, and ongoing treatment coordination. Unlike automated appointment reminders and random drug and alcohol testing notifications, Elevate communications do not follow a predetermined messaging schedule.
EHR Appointment Reminders
Appointment reminders are generally sent approximately 48 hours, 24 hours, and 1 hour before scheduled appointments.
Actual reminder frequency depends on the number of scheduled appointments and the client's authorized communication methods.
Twilio Random Testing Notifications
Random testing notifications are generally sent at approximately 7:00 AM Mountain Time on days when a client is selected for testing.
Message frequency varies depending on the client's treatment program and monitoring requirements, with a maximum of one testing notification per day and three testing notifications per week.
Message and Data Rates
Message and data rates may apply to SMS communications through Elevate, the Electronic Health Record (EHR), and Twilio, depending on the client's mobile carrier and service plan.
E. Opt-Out & HELP Instructions
Clients may decline, modify, or withdraw authorization for electronic communications according to the applicable communication system.
Clients who have not authorized automated appointment reminders or random drug and alcohol testing notifications are not enrolled in those messaging programs and do not need to opt out.
Elevate Direct Client Communication
Elevate provides direct, two-way telephone and text messaging communication under Oxytocin Clinic's general communication authorization.
Clients may request that telephone calls or text messages through Elevate be discontinued at any time by notifying their assigned clinician or contacting Oxytocin Clinic directly.
Upon receiving an opt-out request, Oxytocin Clinic will document the request, update the client's communication preferences, and cease the requested Elevate communications.
Opting out of Elevate communications does not automatically revoke separately authorized EHR appointment reminders or Twilio random testing notifications unless the client requests that all clinic communications cease.
Discontinuing Elevate communications does not eliminate the client's treatment, appointment, testing, court, probation, or other monitoring responsibilities.
EHR Appointment Reminders
Clients who have not provided written authorization for automated appointment reminders are not enrolled in the EHR notification program and do not need to opt out.
Clients who previously authorized appointment reminders may modify or revoke their authorization at any time by contacting Oxytocin Clinic and requesting an update to their communication preferences.
Upon receiving a request, Oxytocin Clinic will update the client's EHR communication preferences and discontinue the affected automated notifications.
Opting out of EHR appointment reminders does not automatically revoke separately authorized Twilio random testing notifications or Elevate communications unless the client requests that all clinic communications cease.
Twilio Random Testing Notifications
Clients who have not provided written authorization for automated random drug and alcohol testing notifications are not enrolled in the Twilio SMS notification program and do not need to opt out.
Clients who previously authorized random testing SMS notifications may withdraw their consent at any time.
Reply STOP to opt out of automated random testing notifications.
Reply HELP to receive automated information about contacting Oxytocin Clinic.
For nonemergency assistance, contact Oxytocin Clinic directly at (406) 314-6565.
Twilio notifications are automated and are not monitored for individual client conversations. Replying to a notification does not contact the client's counselor or constitute a request for alternative testing arrangements.
When a client opts out of Twilio notifications, the affected telephone number is blocked from further automated messages through Twilio's applicable suppression procedures. Oxytocin Clinic also maintains a separate opt-out tracking process to document and honor the client's request.
Clients who decline or revoke random testing SMS authorization must call Oxytocin Clinic every Monday through Friday between 8:30 AM and 9:00 AM Mountain Time to determine whether they have been selected for required testing.
Clients selected for required random drug or alcohol testing must report during the following collection hours:
Kalispell: Monday–Friday, 8:30 AM–4:30 PM.
Libby: Monday–Friday, 12:00 PM–7:00 PM.
If a client cannot complete testing during established collection hours, the client must contact their individual counselor that same day, before the collection period ends, to request approval for alternative testing arrangements.
Declining or revoking SMS authorization does not eliminate appointment attendance, testing, treatment, court, probation, or other monitoring requirements.
Opting out of Twilio notifications does not automatically revoke separately authorized EHR appointment reminders or Elevate communications unless the client requests that all clinic communications cease.
Opt-Out of All Clinic Communications
Clients may request that all nonessential telephone calls and text messages from Oxytocin Clinic be discontinued, regardless of the communication system used.
When a client requests that all clinic communications cease, Oxytocin Clinic will document the request, update the client's communication preferences, and discontinue applicable telephone and SMS communications through Elevate, the EHR, and Twilio.
We will honor a request to stop all clinic communications across all three systems, rather than limiting it to the system through which the request was received.
Opting out of electronic communications does not eliminate the client's responsibility to comply with treatment, appointment, random drug and alcohol testing, court, probation, or other monitoring requirements.
Clients who decline or discontinue random testing SMS notifications must follow the clinic's established daily call-in procedures.
Oxytocin Clinic may continue communications when required or otherwise permitted by applicable law, using an appropriate authorized communication method.
Message Delivery and Carrier Responsibility
Electronic message delivery depends on mobile carrier availability, network conditions, device settings, and accurate contact information.
Carriers are not liable for delayed or undelivered messages.
Oxytocin Clinic cannot guarantee the delivery or receipt of individual electronic notifications. Clients remain responsible for meeting applicable appointment, treatment, testing, and monitoring obligations regardless of whether an electronic notification is received.
F. Data Sharing & Disclosure
Oxytocin does not sell client personal information, mobile telephone numbers, or SMS consent information.
Oxytocin does not share SMS opt-in data, mobile numbers, or consent information with third parties or affiliates for marketing or promotional purposes.
Information necessary to provide authorized communications may be disclosed to approved service providers, including Elevate, the EHR provider, Twilio, telecommunications carriers, and other vendors involved in delivering communications, when permitted by applicable law and subject to required privacy and confidentiality safeguards.
Oxytocin maintains appropriate confidentiality protections for substance use disorder treatment information, including applicable HIPAA and 42 CFR Part 2 requirements.
Oxytocin recognizes applicable federal and state restrictions on unauthorized communications, including relevant Do Not Call and consumer communication requirements.
G. Security of Your Information
Oxytocin takes reasonable administrative, technical, and organizational measures to protect personal and communication information.
Access to communication records is restricted according to staff responsibilities and applicable confidentiality requirements.
Although reasonable safeguards are maintained, standard SMS communications may not be completely secure. Messages may be viewed by individuals who have access to the recipient's telephone, and delivery may be delayed or unsuccessful.
Oxytocin Clinic limits the information contained in electronic communications through Elevate, the Electronic Health Record (EHR), and Twilio to what is reasonably necessary for the intended communication. The clinic takes appropriate precautions to minimize unnecessary disclosure of confidential client information, including protected health information and substance use disorder treatment records, in accordance with applicable HIPAA and 42 CFR Part 2 requirements.
Automated appointment reminders and random drug and alcohol testing notifications are limited to necessary scheduling and testing information. Direct communications through Elevate may include additional treatment-related information when appropriate and authorized, subject to applicable privacy and confidentiality safeguards.
Clients are responsible for notifying Oxytocin when their contact information or communication preferences change.
H. Record-Keeping & Proof of Consent
Oxytocin maintains records supporting its authorized electronic communications, including:
-
Signed appointment reminder authorizations.
-
Signed random testing SMS authorizations.
-
Client communication preferences and consent dates.
-
Records of consent modification and revocation.
-
SMS opt-out requests and related processing records.
-
Documentation of available message transmission, delivery, and notifications.
Oxytocin maintains records in accordance with applicable treatment recordkeeping, privacy, and retention requirements, including relevant TCPA, carrier, and Campaign Registry requirements.
Oxytocin maintains separate documentation for EHR appointment reminders and Twilio random testing notifications, as appropriate to each system.
I. Changes to This SMS Privacy Policy
Oxytocin may update this SMS Privacy Policy to reflect changes in applicable laws, communication practices, technology, service providers, or privacy and security procedures.
Material changes will be communicated through appropriate authorized channels or by posting an updated Privacy Policy on the Oxytocin website.
Changes to this Privacy Policy do not automatically expand a client's existing SMS authorization. Additional consent will be obtained when required.
J. Contact Us
If you have questions about this SMS Privacy Policy, wish to review your communication preferences, or want to modify or revoke an authorization, please contact Oxytocin Clinic directly.
Email: info@oxytocinclinic.com
Phone: (406) 314-6565
Address: 1203 US Highway 2 West, Suite 15, Kalispell, MT 59901
8. Requests, Website & Electronic Forms
Oxytocin does not accept any requests through its webpage, website, website contact form, or online scheduling feature.
Make all requests by contacting the office directly. This includes, but is not limited to:
-
Requests for services
-
Requests for appointments
-
Requests to cancel or reschedule appointments
-
Requests for records
-
Requests for documentation
-
Requests related to billing
-
Requests related to privacy rights
-
Requests to change communication preferences
-
Requests to update SMS preferences
-
Requests to file complaints or grievances
-
Requests for releases of information or consent changes
Oxytocin may use an electronic health record and electronic intake forms when appropriate. Electronic forms are provided or directed by the office and, when applicable, become part of your designated record set. These forms are protected under HIPAA, 42 CFR Part 2, and applicable Montana law.
Oxytocin uses information submitted through office-directed electronic forms only for treatment, payment, health care operations, legal compliance, and other purposes permitted or required by law.
9. Third-Party Service Providers
Oxytocin utilizes trusted third-party vendors to support operations, including:
-
Electronic Health Records
-
Secure telehealth platforms
-
Internal appointment scheduling systems
-
Billing services
-
Payment processing
-
Website hosting for informational purposes only
-
Secure messaging
-
Office-directed electronic forms
-
Analytics necessary for website performance
The website is used for informational purposes only. Oxytocin does not accept requests via its website.
These vendors are contractually required to safeguard protected information in accordance with applicable federal privacy laws.
Required Privacy Statement
All categories above exclude text messaging originator opt-in data and consent; this information will not be shared with any third parties except messaging aggregators and providers necessary to deliver text messaging services.
10. Minors & Parent/Guardian Rights
Oxytocin provides behavioral health and substance use disorder services to adolescents and minors as permitted under Montana law. Parents or legal guardians generally have rights regarding their child's treatment information. However, Montana law recognizes certain circumstances in which minors may consent to treatment or have confidentiality rights independent of a parent or guardian. When Montana law permits, Oxytocin will protect a minor's confidentiality in accordance with applicable legal requirements. We collect only the information necessary to provide treatment, coordinate care, and comply with legal requirements.
11. Your Privacy Rights
You have the right to:
-
Inspect and obtain copies of your health records, subject to applicable federal and Montana law
-
Request amendments to your record
-
Receive an accounting of disclosures
-
Request restrictions on certain disclosures
-
Request confidential communications
-
Receive a paper copy of this Notice
-
Receive notification of certain data breaches
-
File a complaint without fear of retaliation
Some requests may be denied when permitted by federal or Montana law.
You must make requests by contacting the office directly. Oxytocin does not accept privacy requests via its website or webpage.
12. Data Security & Retention
Oxytocin maintains administrative, technical, and physical safeguards designed to protect your information from unauthorized access, use, or disclosure. Oxytocin retains records in accordance with applicable Montana record retention requirements, federal regulations, contractual obligations, and professional standards. When information is no longer required, we securely destroy it or permanently de-identify it, as permitted by law.
13. Changes to This Notice
Oxytocin reserves the right to modify this Privacy Policy and Notice of Privacy Practices at any time. Oxytocin may post updated versions on its website for informational purposes, and they will apply to all information Oxytocin maintains unless otherwise required by law. Posting information on the website does not create a webpage request process. To request information, contact the office directly.
14. Questions or Complaints
If you have questions about this Notice or wish to exercise your privacy rights, please contact the office directly:
Phone: (406) 314-6565
Email: info@oxytocinclinic.com
Address: 1203 US HWY 2 W Ste 15, Kalispell, MT 59901
Oxytocin does not accept questions, complaints, privacy requests, record requests, appointment requests, service requests, billing requests, or communication preference requests through its webpage or website.
If you believe Oxytocin has violated your privacy rights, you may file a complaint with Oxytocin by contacting the office directly or with the U.S. Department of Health and Human Services, Office for Civil Rights (OCR).
You will not be retaliated against for filing a complaint.
Filing a complaint with Oxytocin does not affect your right to file a complaint directly with the U.S. Department of Health and Human Services.